Search - tctmd.com

Displaying 161 - 180 of 39119

Sort: Relevancy | Date

Presentation THT 2026

Development of Cardiomyopathy in Patients with ADHD Treated with Stimulants, Nonstimulants, and No Pharmacotherapy

Presenter: Matthew Ramm

March 03, 2026

Presentation THT 2026

Raise the Heart Rate and Pace the Conduction System: New Trends in Electrophysiology

Presenter: Daniel Joseph Friedman

March 03, 2026

Presentation THT 2026

Devices Are Not Enough: Revitalizing Development of New Drugs for Cardiogenic Shock

Presenter: Alexandre Mebazaa

March 03, 2026

Presentation THT 2026

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Presenter: Edwin Ho

March 03, 2026

Presentation THT 2026

Atrio-Ventricular Interval Modulation (AVIM) for HFpEF

Presenter: David E. Kandzari

March 03, 2026

Presentation THT 2026

CSWG/AHA/C3TN: What Have We Learned From These Real World Registries

Presenter: Shashank Shekhar Sinha

March 03, 2026

Presentation THT 2026

Beyond the Heart and Nerves: Diaphragmatic Stimulation for HFrEF - Viscardia

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Presenter: Akshay Arora

March 03, 2026

Presentation THT 2026

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Presenter: Joe Rossano

March 03, 2026

Presentation THT 2026

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Presenter: Hanna Gaggin

March 03, 2026

Presentation THT 2026

Bioelectric Regulation of Cardiac Remodeling in Heart Failure: Microcurrent Therapy

Presenter: Stefan Anker

March 03, 2026

Presentation THT 2026

The Special Cases of In- and Out-of Hospital Cardiac Arrest

Presenter: Maya Guglin

March 03, 2026

Presentation THT 2026

Identifying and Preventing Toxicity

Presenter: Eric D. Adler

March 03, 2026

Presentation THT 2026

Enhancing Risk Prediction With Novel Approaches To Define Cardiogenic Shock Phenotypes

Presenter: Jonas Sundermeyer

March 03, 2026

Presentation THT 2026

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Presenter: David A. Baran

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Presenter: Nir Uriel

March 03, 2026

Presentation THT 2026

Designing Studies for Gene Therapy for Rare Diseases

Presenter: Barry Greenberg

March 03, 2026

Advertisement

Development of Cardiomyopathy in Patients with ADHD Treated with Stimulants, Nonstimulants, and No Pharmacotherapy

Raise the Heart Rate and Pace the Conduction System: New Trends in Electrophysiology

Devices Are Not Enough: Revitalizing Development of New Drugs for Cardiogenic Shock

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Atrio-Ventricular Interval Modulation (AVIM) for HFpEF

CSWG/AHA/C3TN: What Have We Learned From These Real World Registries

Beyond the Heart and Nerves: Diaphragmatic Stimulation for HFrEF - Viscardia

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Bioelectric Regulation of Cardiac Remodeling in Heart Failure: Microcurrent Therapy

The Special Cases of In- and Out-of Hospital Cardiac Arrest

Identifying and Preventing Toxicity

Enhancing Risk Prediction With Novel Approaches To Define Cardiogenic Shock Phenotypes

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Designing Studies for Gene Therapy for Rare Diseases

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content